GlassScriptPhysician profile
Robert Douglas Orr
NPI 1720043565
$74,023.27
in general payments reported to CMS, 2019-2025
9 companies · $582 in 2025
The $582 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24K · 2020: $2,354 · 2021: $13K · 2022: $23K · 2023: $10K · 2024: $176 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,919 · Food and Beverage: $1,155 · Travel and Lodging: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,919.00 |
| Food and Beverage | $1,154.96 |
| Travel and Lodging | $139.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tyber Medical, LLC | $55,073.00 | 2019-2023 | |
| Stryker Corporation | $17,306.14 | 2019-2024 | Cascadia Interbody System, Everest Spinal System, Serrato |
| Kuros Biosciences USA, INC | $689.72 | 2020-2025 | Magnetos |
| Medtronic, INC. | $378.87 | 2022-2025 | Mazor X System, Stealthstation S8 Platform, Anteralign Spinal System With Titan Nanolock Surface Technology |
| Medtronic USA, INC. | $303.70 | 2019-2020 | |
| Vb Spine LLC | $121.78 | 2025 | Xia 3 |
| Astrazeneca Pharmaceuticals LP | $74.67 | 2023 | Lynparza |
| Zimmer Biomet Holdings, INC. | $40.00 | 2021 | |
| Menarini Silicon Biosystems, INC. | $35.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,395,874.30 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Orr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.